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Factor H (FH) is the major regulator of C3b in the alternative
pathway of the complement system in immunity. FH comprises
20 short complement regulator (SCR) domains, including eight
glycans, and its Y402H polymorphism predisposes those who
carry it to age-related macular degeneration. To better under-
stand FH complement binding and self-association, we have
studied the solution structures of both the His-402 and Tyr-402
FH allotypes. Analytical ultracentrifugation revealed that up to
12% of both FH allotypes self-associate, and this was confirmed
by small-angle X-ray scattering (SAXS), MS, and surface plas-
mon resonance analyses. SAXS showed that monomeric FH has
a radius of gyration (Rg) of 7.2–7.8 nm and a length of 25 nm.
Starting from known structures for the SCR domains and gly-
cans, the SAXS data were fitted using Monte Carlo methods to
determine atomistic structures of monomeric FH. The analysis
of 29,715 physically realistic but randomized FH conformations
resulted in 100 similar best-fit FH structures for each allotype.
Two distinct molecular structures resulted that showed either
an extended N-terminal domain arrangement with a folded-
backC terminus or an extendedC terminus and a folded-backN
terminus. These two structures are themost accurate to date for
glycosylated full-length FH. To clarify FH functional roles in
host protection, crystal structures for the FH complexes with
C3b andC3dg revealed that the extendedN-terminal conforma-
tion accounted for C3b fluid-phase regulation, the extended
C-terminal conformation accounted for C3d binding, and both
conformations accounted for bivalent FH binding to glycosami-
noglycans on the target cell surface.
The alternative pathway of complement is activated by the
spontaneous hydrolysis of C3 into C3u, also known as
C3(H2O). This leads to a positive-feedback amplification of C3
cleavage to form activated C3b that opsonizes pathogenic cells.
To prevent unwanted C3b-mediated host cell damage, comple-
ment factorH (FH)3 regulates complement by acting as a cofac-
tor for factor I (FI) to cleave C3b (1–3), competing with factor B
(FB) to interferewith the formation of theC3 convertaseC3bBb
(4), and accelerating the decay of the C3bBb complex (2, 5).
These activities occur in the fluid phase and less effectively at
the host cell surface (6).
Disrupted complement regulation is associated with age-re-
latedmacular degeneration (AMD), themost common cause of
blindness in the West (7–10), and also with atypical hemolytic
uremic syndrome (aHUS), C3 glomerulopathy (C3G), and Alz-
heimer’s disease (11–13). In early stage AMD, sub-retinal pig-
ment epithelial deposits known as drusen develop within
Bruch’s membrane, which is an extracellularmatrix layer inter-
posed between the retinal pigment epithelium and the choroi-
dal vasculature (14). Drusen contains oxidized lipids, carbohy-
drates, cellular materials, and over 200 proteins, including FH
and other complement components (10, 15, 16).
FH is composed of 20 short complement regulator (SCR)
domains of61 residues connected by linkers of 3–8 residues
in length (Fig. 1) (17). Eight out of nine potential N-glycosyla-
tion sites in FHare occupied by biantennary disialylated glycans
(18). Functionally, FH has multiple binding sites for its major
ligands C3b, the C3d fragment, C-reactive protein (CRP), and
two host-cell markers heparin, which is an analogue of the nat-
ural ligand heparan sulfate (HS), and sialic acid (19–21). Each
ligand binds to FH weakly with micromolar KD values (22) at
specific SCR domains summarized in Fig. 1. For example, FH
has two binding sites for heparin at SCR-7 and SCR-20 (22–26),
and weak independent interactions with heparin at SCR-7 and
SCR-20 result in bivalent bindingwith an overall greater affinity
than either site on their own (21, 27). The dimerization of FH at
high concentrations was first reported by X-ray and neutron
scattering (28). FH also self-associates at each of SCR-6/8 and
SCR-16/20 with micromolar KD values; the sequential daisy-
chaining of these two dimer sites leads to FH oligomers
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(26, 29–31). The formation of dimers and tetramers of FHmay
also be involved in host cell recognition essential for comple-
ment regulation (32). However, it is often presumed that FH is
monomeric (33).
Genetic variants in FH are associated with disease (34). In
AMD, FH SCR-7 harbors the AMD-risk polymorphism Y402H
(7–10). Individuals homozygous for His-402 have a 6-fold
increased risk of developing AMD compared with 2.5-fold for
His-402 heterozygotes (35). The presence of His-402 weakened
heparin binding to both FH SCR-6/8 and full-length FH (36,
37), FH binding to CRP (38, 39), and full-length FH binding to
HS in Bruch’s membrane (40). For the development of AMD,
age-related changes in glycosaminoglycan structures such as a
decrease in the sulfation of HS, together with the presence of
FH His-402, have been proposed to reduce FH binding over
time. At host cell surfaces, FH His-402 showed weaker SCR-7
binding to eye tissue-specific HS only (41). In opposition to
these observations of weaker HS binding for the His-402 allo-
type, His-402 in SCR-6/8 was seen to be bound to the highly-
sulfated glycosaminoglycan analogue sucrose octasulfate using
X-ray crystallography, whereas no such crystals were reported
for the Tyr-402 allotype (42). Although the statistical associa-
tion of Y402H with AMD is one of the strongest, many other
complement variants in CFH and other complement genes
associate also with AMD, suggesting that AMD is caused by
several different molecular mechanisms. For example, at the
other heparin-binding site on FH, SCR-20 harbors the AMD-
risk rare variant R1210C (43). AMD is associated with another
12 rare variants in FH in its signal peptide or in SCR-1, SCR-3/5,
SCR-8, SCR-16, or SCR-18 (44). AMD is also associated with
the protective polymorphism V62I in SCR-1 (10, 45), common
synonymous and noncoding variants in a region overlapping
the CFH gene (36, 46, 47), and genetic variants in complement
C3, CFI, CFB, and C9 (44, 49).
Additional insights into molecular mechanisms for AMD
may be gained by studying both the self-association and overall
solution structure of FH in the context of the Y402H polymor-
phism. To date, full-length FH has proven too large, flexible,
and glycosylated for high-resolution structural determination
by crystallography orNMR. Preliminarymolecularmodeling of
small angle X-ray scattering (SAXS) curves revealed that full-
length FH in solution has a folded-back SCR structure that is
affected by ionic strength (26, 50, 51). To examine the effect of
the Y402H polymorphism on FH self-association and its solu-
tion structure, we submitted each of the homozygous FH Tyr-
402 andHis-402 to analytical ultracentrifugation (AUC), SAXS,
MS, and surface plasmon resonance studies. Both FH allotypes
self-associated to form oligomers, and SAXS curve extrapola-
tion to zero concentration showed that both FH allotypes
exhibited similar overall structures. Our preliminary FH mod-
eling was based on just 11–14 high-resolution SCR structures
and an initial molecular dynamics approach tomodel the inter-
SCR linkers (26, 51). Here, the FHmodeling is much improved
by starting from 17 high-resolution SCR structures (Fig. 1;
Table 1) (26, 45, 52, 53) and utilizing a much improved Monte
Carlo atomistic modeling method for the full-length FH struc-
ture, including the eight FH glycan chains (54). The resulting
SAXS best-fit structural ensembles corresponded to the most
accurate FH models determined to date. These ensembles
revealed two different extended and folded-back FH domain
arrangements that favor two different modes of FH binding to
either C3b or C3d. Both arrangements accounted for the biva-
lent binding of FH to HS-coated cell surfaces. The outcome of
two different FH conformations provides new insights into the
way in which FH regulates complement C3b activity.
Results
Sedimentation velocity analyses of the two FH allotypes
AUC studies use macromolecular sedimentation behavior
under a high centrifugal force to determine sizes and shapes
(55). The full-length FHTyr-402 andFHHis-402 allotypeswere
purified from the plasma of genotyped volunteers (Table 3) as
single peaks from size-exclusion chromatography (Fig. 2) that
gave clean single bands by SDS-PAGE (29). Here and below, FH
was genotyped for both Y402H and I62V polymorphisms, with
our focus on the former, whereas the presence of Val-62 or
Ile-62 in the FH samples was noted for completion but was not
investigated further (56). Previous fluid-phase activity assays
using C3u and FI with both FH allotypes showed that both
demonstrated similar C3u cleavage rates (57).
The higher oligomers previously observed for heterozygous
FH (26, 29–31) were reassessed using AUC sedimentation
velocity experiments on five homozygous FH Tyr-402 and five
homozygous FH His-402/Val-62 samples at three concentra-
tions between 0.5 and 2.1 mg/ml in HEPES buffers (10 mM
HEPES, 137 mM NaCl, pH 7.4). Similar sedimentation bound-
aries were observed for the two allotypes (Fig. 3A), and these
Figure 1. Cartoon of the 20 SCR domains in FH. Each SCR domain is represented by an ellipse color-coded to indicate the starting atomistic structure (green,
X-ray crystallography; purple, NMR; orange, homology modeling). Ribbon views of the seven SCR structures used to model FH are shown above the cartoon,
together with their PDB codes. The asterisks signify newer SCR structural models that became available after the previous full-length FH models were
published. Below the cartoon, the FH functional binding sites are denoted by horizontal bars for each of C3b, C3d, factor I, heparan sulfate, and sialic acid.
Solution structures of FH Tyr-402 and His-402
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were fitted using size-distribution analyses c(s). Good fits with
low residuals were obtained in all 10 cases. The mean sedimen-
tation coefficient s20, w of monomeric FH (Tyr-402) at 50,000
rpmwas 5.69 0.03 S and that for FH (His-402)was identical at
5.67 0.04 S (peak 1 in Fig. 3B). Both values (Table 3) agreewell
with previous s20, w values of 5.3 0.1 S (50) and 5.65 0.05 S
(29) forWTmonomeric FH in 137mMNaCl. Conversion of the
c(s) distribution tomass distribution plots c(M) showed that the
major peak 1 corresponded to a molecular mass of 147  10
kDa for FH Tyr-402 and 147  11 kDa for FH His-402. Both
values agreed with the sequence-calculated molecular mass of
154 kDa for both allotypes and previous c(M) mass determina-
tions of 142 2 kDa for native FH (29). Integration showed that
the dimer and trimer peaks comprised 4.0 1.9 and 2.1 0.7%,
respectively, for FH Tyr-402 and 5.7  1.5 and 2.5  0.6%,
respectively, for FH His-402. Averaging the c(s) distributions
established the observation of these dimer and trimer peaks
(Fig. 3B). Hence, at 1.1 mg/ml, the His-402 allotype formed
slightly more dimer and trimer than the Tyr-402 allotype, but
the difference was small (peaks 2 and 3 in Fig. 3B). The mean
s20, w value of dimeric FH Tyr-402 was 7.57  0.36 S, and that
for dimeric FH His-402 was similar at 7.69 0.40 S (peak 2 in
Fig. 3B). Themean s20, w value of trimeric FHTyr-402was 9.3
0.7 S and that for trimeric FHHis-402 was similar at 9.4 0.8 S
(peak 3 in Fig. 3B). These values agree well with previous values
of 7.3 0.2 and 9.2 0.2 S for heterozygousWTFHdimers and
Table 1
Sources of molecular SCR structures in FH
FH domain(s) PDB code Ref. Method Used in previous FH model
SCR-1/4 2WII 52 X-ray crystallography 51
SCR-1/3 2RLP/2RLQ 45 NMR 26
SCR-4 112 Homology 26
SCR-5 95 NMR 26, 51
SCR-6/8 2V8E 113 X-ray crystallography 26, 51
SCR-9a 112 Homology 26, 51
SCR-10/11b 4B2R 114 NMR
SCR-10/13 112 Homology 26
SCR-11/12b 4B2S 114 X-ray crystallography
SCR-12/13 2KMS 53 NMR 51
SCR-14a 112 Homology 26, 51
SCR-15/16 1HFH 115 NMR 26, 51
SCR-17a 112 Homology 26, 51
SCR-18 112 Homology 26
SCR-18/20b 3SW0 79 X-ray crystallography
SCR-19/20 2G7I 48 X-ray crystallography 26, 51
aOnly homology models are available for this (Fig. 1).
bNewer SCR structural models published after the previous full-length FH models were published (Fig. 1).
Figure2. Size-exclusiongel filtrationofhomozygousFH.Pairs of homozy-
gous purified FH Tyr-402 and His-402 at A, 0.9 mg/ml, and B, 0.3 mg/ml, were
loaded onto a SuperoseTM 6 prep grade XK 16/60 column immediately after
AUC sedimentation velocity experiments. Here and below, data for the Tyr-
402 and His-402 allotypes are denoted in blue and red, respectively.
Figure 3. Sedimentation velocity c(s) size-distribution analyses for FH
Tyr-402 and FH His-402. All analyses correspond to 1.1 mg/ml FH. A, repre-
sentative sedimentation boundary fits corresponding to FH Tyr-402 (blue)
and FH His-402 (red) are shown using only every 10th scan for clarity. The
experimental data are shown in black. B, peaks 1–3 in the c(s) analyses for five
FH Tyr-402 and five FHHis-402 samples (red) are shown in different line styles.
The averaged c(s) plots for FH Tyr-402 and FH His-402 are shown at the right.
The monomer peak 1 at 5.7 S is normalized to 100. C, full c(s) analyses for FH
Tyr-402 and FH His-402 reveal up to nine FH oligomer species starting with
peaks 1 and 2 formonomer and dimer and extending to peak 9 for presumed
nonamers. D, proportion of FH oligomers was derived by integration of the
c(s) analyses for peaks 2–9 for the five FH Tyr-402 and FH His-402 samples at
concentrations between 0.5 and 2.4 mg/ml. Statistical error bars are shown
where visible. Themean proportion of oligomers is shown as horizontal lines.
Solution structures of FH Tyr-402 and His-402
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trimers, respectively, in a range of NaCl concentrations and pH
values, and their size increases with the increase in FH concen-
tration (26, 29). In general, reaction boundaries give single c(s)
peaks that correspond to the co-sedimentation of two different
species in rapid equilibrium and exhibit well-defined sedimen-
tation coefficients between the values of the two different spe-
cies (58). The observation of distinct dimer and trimer c(s)
peaks thus corresponded to slow equilibria between monomer,
dimer, and trimer FH on the time scale of sedimentation.
AUC had showed previously that FH was described by a
reversible monomer–dimer equilibrium up to 1.3 mg/ml and
that heterozygous FH above 2 mg/ml forms irreversible high
oligomers (29). To assess these with homozygous FH, size-ex-
clusion chromatography was performed after the proteins had
sedimented by AUC. After resuspending by gentle shaking,
size-exclusion chromatography showed that the single homo-
geneous FH peak between 65 and 75 ml was supplemented by
small additional peaks corresponding to irreversible FH oligo-
mers that eluted earlier between 55 and 65 ml in all cases, as
expected (Fig. 2). The main monomer peak was eluted at the
same position in each case, indicating no structural differences
between the allotypes.
In heterozygousWT FH, oligomers from tetramers to nona-
mers have previously been observed at concentrations as low as
0.4 mg/ml (26, 29). Here, their existence was also observed for
FHTyr-402 at 1.1mg/ml, and the s20, w values of peaks 4–9 (Fig.
3C) were 11.9 1.0 S, 14.7 0.8 S, 17.1 0.7 S, 19.4 1.0 S,
22.1 1.0 S, and 25.0 0.7 S in that order. For FH His-402 at
1.1mg/ml, the s20, w values of peaks 4–9 (Fig. 3C) were in agree-
ment at 11.9  0.9 S, 14.3  0.5 S, 16.7  0.4 S, 18.7  0.6 S,
21.3 0.5 S, and 24.8 0.7 S in that order. Integrations of peaks
2–9 yielded the percentages of oligomers (Fig. 3D). Values of
11.7  2.0 and 12.8  2.7% of oligomers were seen for FH
Tyr-402 and FH His-402, respectively, with this being margin-
ally higher for FH His-402. Both percentages are consistent
with an estimate of 17% of dimers predicted from a self-associ-
ation KD value of 28 M (29).
Mass spectrometry of the two FH allotypes
Because FH self-association had only previously been
reported by AUC, MS of homozygous FH was used to further
examine self-association. MS observes macromolecular assem-
blies and determines their stoichiometry (59). One pair of
homozygous FH Tyr-402/Val-62 and His-402/Val-62 allotypes
was studied shortly after their concentration to about 4 mg/ml
in order to promote the formation of oligomers. The use of 140
mM ammonium acetate buffer, pH 7.0, and 1 M ammonium
acetate buffer, pH 7.0, evaluated two ionic strengths, given
the decrease in oligomers with an increase in the NaCl concen-
tration (26). Ammonium acetate was used because this is vola-
tile in the gas phase used for measurements, unlike the HEPES
buffer used for AUC. All four samples showed signals with five
to six components at mass/charge (m/z) ratios that corre-
sponded to the FHmonomer with charges of23 to27 (Fig.
4). For FH Tyr-402, the monomer mass was determined to be
150 kDa in 140 mM ammonium acetate and 157 kDa in 1 M
ammonium acetate (Fig. 4, A and B). Similar masses were
obtained for FHHis-402, giving 156 kDa in 140mM ammonium
acetate and 150 kDa in 1 M ammonium acetate (Fig. 4,C andD).
These masses agreed well with those from AUC (26, 29). They
also agreed with the sequence-calculated mass of 154 kDa for
FHbased on eight glycan chains (18). The variability of themass
determinations was attributed to glycan heterogeneity in FH.
Dimer and trimer FH were also observed in the mass spectra
(Fig. 4). For both FHTyr-402 andHis-402, the dimer and trimer
were seen in 140 mM ammonium acetate, whereas only the
dimer was seen in 1 M ammonium acetate. Their molecular
masses were determined to be 307 and 457 kDa and 309 kDa,
respectively (Fig. 4, A and B). Similar results were obtained for
FH His-402, now giving masses of 306 and 455 kDa in 140 mM
ammonium acetate, and 299 kDa in 1 M ammonium acetate
(Fig. 4, C and D). Peak integrations gave the proportions of
monomer, dimer, and trimer as 73, 24, and 4% for FH Tyr-402
Figure 4.Mass spectrometry of FHTyr-402 and FHHis-402. The FHmono-
mer, dimer, and trimer peaks are marked by M, D, and T and their measured
molecular weights. A, homozygous FH Tyr-402/Val-62 was studied at 3.9
mg/ml (25.3 M) in 140 mM ammonium acetate buffer, pH 7.0. B, same FH
Tyr-402/Val-62 sample was studied at 4.4 mg/ml (28.6 M) in 1 M ammonium
acetate buffer, pH 7.0. C, homozygous FH His-402/Val-62 was studied at 3.9
mg/ml (25.3 M) in 140 mM ammonium acetate buffer, pH 7.0. D, same FH
His-402/Val-62 sample was studied at 3.6 mg/ml (23.4 M) in 1 M ammonium
acetate buffer, pH 7.0.
Solution structures of FH Tyr-402 and His-402
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and 76, 17, and 6% for FH His-402 in 140 mM ammonium ace-
tate (Fig. 4,A andC). The appearance of dimer and trimer peaks
in the mass spectra validates the observation of dimer and
trimer byAUC (Fig. 3B), and the summed integrationwas com-
parable with 11.7–12.8% by AUC from Fig. 3D. At 4 mg/ml,
dimer formation was estimated as 37% from a KD value of 28
M, with this being comparable with the observed amounts of
dimer. The proportions of monomer and dimer changed to 90
and 10% for FH Tyr-402 and 98 and 2% for FH His-402 in 1 M
ammonium acetate (Fig. 4, B and D). The reduction of dimer
and the disappearance of trimer in 1 M ammonium acetate
agrees well with the effect of increased ionic strength in reduc-
ing FH self-association (26). No difference was detectable
between the two allotypes.
Surface plasmon resonance of the two FH allotypes and FH
SCR-6/8
Surface plasmon resonance (SPR) of the binding of solution-
phase FH to surface-immobilized FH further enabled FH self-
association to be monitored (60). 800 RU of each of homozy-
gous FH Tyr-402 and FHHis-402/Val-62 were immobilized on
CM3 chips. Equilibrium experiments were performed by flow-
ing FH Tyr-402 over the chip at eight concentrations between
1.3 and 10.9 M and FHHis-402 at concentrations between 1.3
and 12.3M inHEPES buffer. The binding of both FH allotypes
to their immobilized FH partner was observed at all concentra-
tions (Fig. 5, A and B) indicating that FH self-association pro-
ceeded in physiologically relevant conditions. In equilibrium
analyses, the individual sensorgrams could not be fitted to a 1:1
binding kineticmodel (data not shown). This key outcome indi-
cated that FH self-association could not be explained as a 1:1
model and that more than one self-association site existed in
FHwith different affinities, in agreementwith themultiple olig-
omers seen by AUC (29). Alternative models to fit the SPR data
were not attempted because of the complication that both the
ligand and analyte showed bivalent binding for each other. The
maximum binding responses were used to fit a steady-state
affinity model. An estimated dissociation constant KD value of
8.0 M with a 2 value of 2.6 RU2 was determined for FH Tyr-
402, which was almost identical to an estimated KD value of 6.7
Mwith a2 value of 6.5 RU2 determined for FHHis-402 (Fig. 5,
A and B). Both values were smaller than the KD value of 28 M
determined for WT FH in solution by sedimentation equilib-
riumAUC (29). The stronger self-association seen by SPR than
by AUC may result from different avidity effects at a surface
that amplifies the strength of binding, although the linearity of
the binding data in a comparatively lowFHconcentration range
precluded a quantitative comparison with the AUC value.
The SPR results were examined further using the SCR-6/8
fragment. Each SCR-6/8 allotype was immobilized to a CM4
chip up to 150 RU, and the His-402 allotype was also immobi-
lized up to 400 RU on a third chip (Fig. 5,C andD). The binding
of SCR-6/8 Tyr-402 was studied between 0.1 and 0.8 mg/ml
(5–40 M). The binding of SCR-6/8 His-402 was studied
between 0.1 and 0.6 mg/ml (5–28 M). Both allotypes self-as-
sociated with each other. The immobilized Tyr-402 allotype
showed the same binding affinities to both allotypes (Fig. 5C).
However, immobilized His-402 allotype showed a higher self-
association withHis-402 thanwith Tyr-402 (Fig. 5D). This sup-
ported earlier AUC experiments suggesting that the His-402
allotype of SCR-6/8 self-associatedmore than the Tyr-402 allo-
type (30). The KD values could not be determined from steady-
state affinity fits because theKD valueswereweaker than 40M;
however, this outcome agreed with the KD value of 40 M from
AUC (30). Comparison of this value with the lowerKD values of
28 M for FH self-association by AUC (29) and 7–8 M by SPR
Figure 5. Surface plasmon resonance analysis of FH Tyr-402 and FH His-
402 self-association. The sensorgrams are shown after subtraction of that
recorded with the buffer only. In the right panels, no KD values were deter-
mined because these were greater than 40 M. A, 800 RU of homozygous FH
Tyr-402/Val-62 was immobilized on a CM3 chip. FH Tyr-402/Val-62 was ana-
lyzed at eight concentrations of 0 M (measured twice), 1.30 M (twice), 3.24
M (twice), 4.53 M, 6.48 M (twice), 7.77 M, 9.72 M (twice), and 10.93 M
from bottom to top. FH His-402/Val-62 was analyzed at eight concentrations
of 0 M (twice) and 1.30, 3.24, 4.86, 6.48, 8.42, 10.37, and 12.31 M. Here and
below, binding affinities were fitted using the maximum response values. B,
800 RU of homozygous FH His-402/Val-62 was immobilized on a CM3 chip.
The same FH Tyr-402/Val-62 and FH His-402/Val-62 concentrations were
used. C, 150 RU of SCR-6/8 Tyr-402 was immobilized on a CM4 chip. SCR-6/8
Tyr-402 was analyzed at concentrations of six concentrations of 0M (twice),
5 and 10 M (twice), 19 M, 29 M (twice), and 37 M from bottom to top. For
theHis-402allotype, six concentrationsof 0M (twice), 5 and10M (twice), 19
and 29 M (twice), and 37 M were used, each measured in duplicate. D, 400
RU of SCR-6/8 His-402 was immobilized on a CM4 chip The binding affinities
were likewise fitted using themaximum response values (open circles). A sec-
ond experiment with 150 RU of SCR-6/8 His-402 immobilized on a CM4 chip
and six concentrations of 0, 5, 10, 15, 20, and 22 M SCR-6/8 is also shown
(filled circles).
Solution structures of FH Tyr-402 and His-402
17170 J. Biol. Chem. (2018) 293(44) 17166–17187
 at U
CL Library Services on January 23, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(above) showed that other self-association sites must exist in
FH as well as in SCR-6/8.
Human serum albumin is the most abundant protein in
serum, being present at 35–50 mg/ml. As a control of potential
nonspecific protein–protein interactions that might influence
FH self-association, further SPR experiments were performed
with solution-phase FH Tyr-402 and His-402 flowed over
immobilized FH His-402 in the presence of up to 6 and 25
mg/ml human serum albumin (Fig. 6, A and B). FH self-associ-
ation continued to be observed even in the presence of high
amounts of albumin (Fig. 6, C and D).
X-ray scattering of the two FH allotypes
X-ray scattering is a diffraction method to determine solu-
tion structures ofmacromolecules in randomorientations (61).
Here, two pairs of homozygous FH Tyr-402 and FH His-402/
Val-62 samples (Table 3) were each freshly prepared and stud-
ied in two different sessions in five concentrations between 0.4
mg/ml (2.6 M) and 3.3 mg/ml (21.4 M) in HEPES buffer.
Excellent signal-to-noise ratios were obtained with no detecta-
ble effect from radiation damage. Linear Guinier fits at low Q
values (whereQ 4 sin /; 2 scattering angle; wave-
length) gave the radius of gyration (Rg) in satisfactory QRg
ranges below 1.1 (Fig. 7A). The Rg value monitors the degree of
elongation of FH. At larger Q values, the cross-sectional
GuinierRXS fitsmonitor the structural proximity between non-
neighboring SCR domains (denoted as RXS-1) and between
neighboring SCR domains (denoted as RXS-2) (50). Both the
RXS-1 and RXS-2 parameters were likewise obtained from linear
fits within satisfactory QRXS ranges (Fig. 7B). This permitted
comparative data analyses for the four FH samples. At 0.4
mg/ml, the Rg values were 7.54 and 7.97 nm for both FH Tyr-
402/Val-62 samples and were 7.45 and 7.91 nm for both FH
His-402/Val-62 samples. The RXS-1 values were 2.35 and 2.36
nm for FH Tyr-402 and 2.15 and 2.25 nm for FH His-402. The
RXS-2 valueswere 1.77 and 1.76 nm for FHTyr-402 and 1.77 and
1.75 nm for FHHis-402. Because theRg,RXS-1, andRXS-2 param-
eters at 0.4 mg/ml were similar for both allotypes, no confor-
mational differences between the allotypes were detectable.
Both FH Tyr-402 and FHHis-402 showed concentration de-
pendences for I(0)/c, Rg, and RXS-1 but not for RXS-2 (Fig. 7,
D–G). These concentration dependences showed self-associa-
tion for both FH allotypes, the extent of which was similar to
WT FH. The I(0)/c value is proportional to molecular mass.
Assuming the slopes in Fig. 7D corresponded to a monomer–
dimer equilibrium, the KD values were estimated to be 16  4
and 18 2 M for the two FH Tyr-402 samples and 11 3 and
22  8 M for the two FH His-402 samples. These KD values
were comparable with that of 28 M from AUC (29) and those
of 7–8 M from SPR (Fig. 1). The extrapolation of the Rg values
to zero concentration, in order to represent themonomer, gave
values of 7.22–7.77 nm (Fig. 7E; Table 3). These values were
lower than that of 8.90 0.19 nm for WT FH (29); this reduc-
tion was attributed to reduced oligomer formation in
improved homozygous FH preparations. The lower Rg value of
7.22–7.77 nm indicated that FH was even more folded-back in
its SCR domain arrangement than previously thought. The
RXS-1 values at zero concentration were 2.02–2.27 nm, which
were lower when compared with the previous RXS-1 value of
2.51 0.06 nm (29). The mean RXS-2 value was 1.75–1.77 nm,
being similar to the previous RXS-2 value of 1.79 0.01 nm (29).
The distance distribution function P(r) reports the distances
between all pairs of atoms within FH (Fig. 7C). The P(r) curves
gave another calculation of the Rg and I(0) values for FH Tyr-
402 and FH His-402 (Table 3). At 0.4 mg/ml, the Guinier and
P(r) Rg values showed good agreement. The maximum dimen-
sion L of FH resulted from the intercept of the P(r) curves with
zero at large r. The r value of the maximumM in the P(r) curve
gives the most commonly occurring distance within FH. The
two FH allotypes showed similar concentration dependences
in their P(r) curves and L values (Fig. 7C), indicating similar
solution structures for the two allotypes. For FH Tyr-402, a
concentration-independent peakM1 was seen at r 5.3 0.7
nm, and a concentration-dependent second peakM2 was seen
at r 11 nm at 3.3 mg/ml. For FHHis-402,M1was unchanged
at 4.9  0.4 nm, and M2 was also 11 nm at 3.3 mg/ml. The
concentration dependence ofM2 reflected FHoligomer forma-
tion. At 0.4mg/ml, theL valueswere 28–29 nm for FHTyr-402,
and 26–28 nm for FH His-402 (Table 3), but were increased at
higher concentrations (Fig. 7C). These L valueswere lower than
those previously reported (29), and this is attributable to a
reduced FH oligomerization at lower concentrations.
In normalized Kratky analyses of (QRg)2I(Q)/I(0) versus
QRg for the four FH experimental curves (62), a clear peak was
obtained in all four cases that tailed off at largeQ.Rg values (data
shown below). These are representative of extended multido-
main proteins tethered by linkers of varying conformations.
Figure 6. Surface plasmon resonance analysis of FH self-association in
the presence of HSA. 800 RU of FH His-402 was immobilized on a CM3 chip.
The sensorgrams are shownafter subtractionof the sensorgramwith thoseof
HSA at the corresponding concentrations. The buffer sensorgram is shown at
the bottom. A, FH Tyr-402/Val-62 at 4.53 M was analyzed with HSA at con-
centrations between 0 and 6 mg/ml. B, FH His-402 at 4.53 M was analyzed
with HSA at concentrations of 0–26 mg/ml. C and D, bar charts show the
maximum responses from A and B, respectively. Error bars are shown where
large enough to be observed.
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The Tyr-402 and His-402 allotypes showed very similar
peaks at QRg values of 4.22 and 4.28 respectively, indicating
that the two allotypes exhibited similar extended flexible
structures.
FHmodels for the Tyr-402 and His-402 allotypes
The atomistic modeling of the two FH Tyr-402 and two His-
402 scattering curves was initiated using 17 high-resolution
SCR structures, three SCR homology models, and eight glycan
chains to construct an energy-minimized initial FHmodel (Fig.
1 and Tables 1 and 2; see under “Materials and methods”). By
varying the torsion angles at eight inter-SCR linkers, 510,000
FHmodels were created in fourMonte Carlo simulations, from
which 29,715 models were retained for analysis as being physi-
cally realistic without steric clashes. Comparison of the four
extrapolated experimental scattering curves with the 29,715
theoretical curves gave an R-factor versus Rg distribution with a
minimum close to the experimental extrapolated Rg value (Fig.
8). AnRg filter of5%of the experimental value and anR-factor
filter of 5% gave 1240/2678 and 1219/310 best-fit models
for the two Tyr-402 and two His-402 allotypes, respectively;
these are 1–9% of the 29,715 trial models (blue/red, Fig. 8).
The best-fit 100 FH models were selected on the basis of the
lowest R-factors (orange, Fig. 8) of 2.3–3.2 and 2.3–3.6%,
respectively (Table 3).
The s20, w0 values of the best-fit 100 FH models were calcu-
lated using HYDROPRO to be 5.35–5.77 and 5.21–5.61 S and
for the centroid models to be 5.49–5.52 and 5.44–5.51 S, both
for FH Tyr-402 and FH His-402, respectively (Table 3). These
values agreed well with the experimental values of 5.66–5.69 S
(Table 3) and confirmed the outcome of the atomistic model-
ing, given that the mean difference between the modeled and
Figure 7. X-ray scattering analyses of FH Tyr-402 and FH His-402. In the Rg and RXS Guinier analyses, the filled symbols correspond to the I(Q) data used to
determine the Rg or RXS values, and the straight lines correspond to the best fit through those points. TheQRg fit ranges are arrowed. A, Rg plots of ln I(Q) versus
Q2 at lowQ values for FH Tyr-402 (blue) and FH His-402/Val-62 (red) at concentrations of 1.1 mg/ml (E), 2.2 mg/ml (‚), and 3.2 mg/ml (). TheQ fit range was
0.09–0.13 nm1. B, corresponding cross-sectional RXS-1 and RXS-2 fits of ln I(Q).Q versus Q
2 values are shown usingQ fit ranges of 0.16–0.26 and 0.4–0.8 nm1,
respectively. C, distance distribution function P(r) analyses are shown at concentrations of 0.4, 0.7, 1.1, 2.2, and 3.3mg/ml.D–G, concentration dependences of
the I(0)/c, Rg, RXS-1, and RXS-2 parameters are shown for FH Tyr-402 and FH Tyr-402/Val-62 (blue; F and Œ) and FH His-402/Val-62 (red; F and Œ). Each value was
measured in quadruplicate and then averaged and fitted by linear regression except in G when the mean was shown. Statistical error bars are shown where
visible.D, I(0)/c intensities weremeasured in two beam sessions, resulting in two different pairs of lines. E, the Rg values at zero concentrationwere 7.39 0.25
and 7.35 0.13 nm (FH Tyr-402) and 7.22 0.15 and 7.77 0.27 nm (FH His-402) (Table 3). F, RXS-1 values at zero concentration were 2.21 0.06 and 2.27
0.06 nm (FH Tyr-402), and 2.02 0.06 and 2.15 0.06 nm (FH His-402). G, averaged RXS-2 values were 1.77 and 1.77 nm (FH Tyr-402) and 1.76 and 1.75 nm (FH
His-402).
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experimental values should be 0.21 S for related macromol-
ecules, including antibodies (63). Like antibodies that are also
considered to be flexible molecules, HYDROPRO was effective
in calculating the s20, w0 values; this was attributed to the use of
the averaged best-fit solution structures. The calculations were
much improved to those of the 2009 FH modeling, which gave
4.91–5.01 S from older scattering models that in retrospect
were too elongated (26).
NT-COMand CT-COM separation distributions
The best-fit SCR arrangements within the 29,715 trial FH
models were shown to be bimodal using histograms of their
N-terminal -carbon (NT) and C-terminal -carbon (CT) to
COM separations (Fig. 9). Longer separations corresponded to
extended SCR arrangements in FH; shorter separations corre-
sponded to a folded-back bent one.
(i) For all 29,715 models, the NT-COM and CT-COM sepa-
rations corresponded to similar ranges of 0.5–21.8 and 0.8–
22.4 nm, respectively (Fig. 9,A andD). However, the most pop-
ulated NT-COM separations were short ones (3–5 nm) that
tailed off after16 nm. In distinction, the most populated CT-
COMseparationswere long ones (14–16 nm) followed by short
ones (5 nm) (Fig. 9,A andD). TheNT-COMseparationswere
right-skewed with a skewness coefficient of 0.53, whereas the
CT-COM separations were left-skewed and bimodal with a
skewness coefficient of 0.55. Overall, the separation distri-
butions were uneven and not normally distributed. This un-
expected outcome was attributed to the seven glycans in
SCR-12/18 that perturbed the randomgeneration of physically-
realistic FH structures (Fig. 1) and the asymmetric distribution
of the longest inter-SCR linkers in FH (26).
(ii) For the 1219–1240 filtered FH models, both the NT-
COM and CT-COM distance distributions corresponded to
small subsets of those for all 29,715 models (Fig. 9, B and E).
Density plots showed that these models occupied limited con-
formations when compared with all 29,715 models (insets, Fig.
9, B and E). The separations for both allotypes were bimodal,
being left-skewed for theNT-COMdistances and right-skewed
for the CT-COM distances. Overall, no differences were seen
between the two allotypes.
(iii) For the two sets of 100 best-fit FH models, the two NT-
COM and CT-COM distance distributions were again largely
bimodal distributions (Fig. 9, C and F). Similar bimodal results
were obtained for the fits with the other pair of FHTyr-402 and
FH His-402 experimental curves (distributions not shown).
For the filtered and top 100 models, statistical analyses were
performed to confirm that the separation distance distributions
(Fig. 9) were unaffected by sampling bias. The best-fit 100mod-
els were not necessarily a converged subset of the filtered mod-
els as seen in other modeling (64). A nonparametric (i.e. no
underlying assumption) Kolmogorov-Smirnov test (data not
shown) was thus used to indicate that the best-fit distances for
NT-COM and CT-COM were either short or long and were
independent of any sampling bias observed in all 29,715 mod-
els. This suggested that FH existed in two conformations.
The full FH SCR domain arrangement was examined using
pairs of NT-COM and CT-COMdistances. The 29,715 separa-
tions were nonrandomly distributed between 1 and 25 nm,
showing that a broad range of FH conformations had been gen-
erated as desired (Fig. 10, A and B). The most sampled best-fit
NT-COM and CT-COM separations occurred at 1–10 and
12–17 nm, respectively, at the top left-hand corner. The second
Table 2
Homology modeling of the SCR-9, SCR-14, and SCR-17 domains
Target domain Template domain PDB code Residues Maximum score Total Query cover E value Residue identities
% %
SCR-9 SCR-4 2UWN 148–186 40.1 41.2 68 0.0004 44
SCR-14 SCR-15 3ZD1 5–59 37.5 37.5 100 0.002 36
SCR-17 SCR-18 3SW0 3–59 42.2 77.6 100 0.00007 37
Figure 8. Atomistic modeling searches for the FH solution structure. The
29,715FHmodelswere fitted tooneexperimental scattering curve for eachof
homozygous FH Tyr-402/Val-62 (A) and FH His-402/Val-62 (B), each extrapo-
lated to zero concentration. Gray corresponds to all FH models. The blue/red
subsets corresponds to FH models that passed two filters, namely Rg within
5% of the experimental Rg and an R-factor of5%. Orange corresponds to
the 100 best-fit FH models (see inset). The vertical black lines represent the
experimental Rg for FH Tyr-402 (7.39 nm) and FH His-402 (7.77 nm). The
dashed lines represent the 5% upper and lower boundaries of these Rg
values.
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most sampled best-fit separations occurred as a broad cluster at
5–17 and 2–8 nm, respectively. For the filtered Tyr-402 mod-
els, two structural regions were visible as two dense clusters
in blue, in which the top 100 Tyr-402 models were shown in
orange (Fig. 10A). For the filtered His-402 models, the same
two clusters were seen in red and orange, respectively (Fig.
10B). In contrast, FH models with long NT-COM and CT-
COM separations (15 nm) showed large radii of gyration
and poor fits with R-factors 5% (gray, Fig. 10, A and B).
This analysis showed that FH either has a bent-inwards
N-terminal region and an extended C-terminal region or
vice versa.
Best-fit conformations for FH Tyr-402 and His-402
After superimposition of the top 100 Tyr-402 and His-402
FH structures, visual inspection showed multiple conformers.
To understand these conformers, they were clustered into con-
formational families using principal component analysis (PCA)
(Fig. 11) (65). PCA determines the correlated motions of pro-
tein residues as linearly uncorrelated variables termed principal
components (66). These “essential motions” are extracted from
a covariance matrix of the atomic coordinates of the frames in
the trajectory. The eigenvectors of this matrix each have an
associated eigenvalue that characterizes a mode of the motion
or variance.
The PCA analyses confirmed that two families of FH struc-
tures with either a bent-inwards N-terminal region and an
extendedC-terminal region, or vice versa, were seen. Four PCA
groups accounted for 98.5 and 86.9% of the variances in the top
100 models of each Tyr-402 and His-402, respectively (Fig. 11,
C and G). For each PCA group, the combined NT-COM and
CT-COM separation distances were plotted (Fig. 11,D andH).
The conformational density of each group was represented as
either blue (NT) or red (CT) density, with the centroid FH
model depicted as a black cartoon (Fig. 12). The 60 Tyr-402
models in PCA groups 2–4 corresponded to an extended N
terminus and a bent inwards C terminus (red, green, and blue,
Figs. 11D and 12,B–D). The 40 Tyr-402models in PCA group 1
corresponded to a bent inwards N terminus and an extended C
terminus (black, Figs. 11D and 12A). The 79 His-402 models in
PCA group 5 corresponded to a bent inwards N terminus and
an extended C terminus (black, Figs. 11H and 12E). The 21
His-402 models in PCA groups 6–8 corresponded to a bent
inwards C terminus and an extended N terminus (red, green,
and blue, Figs. 11H and 12, F–H).
Each of the PCA groups 1–8 gave FH structures whose the-
oretical scattering curves I(Q) fitted well with the experimental
Tyr-402 or His-402 curves with low R-factors between 2.4 and
3.8% (Fig. 12). The visual agreementwas good to at leastQ 1.0
nm1. The centroidmodels with an extendedN terminus and a
bent inwards C terminus (Fig. 12, B–D, and F) gave fits similar
to those with a bent inwards N terminus and an extended C
terminus (Fig. 12, A, E, G, and H). The theoretical distance
distribution curves P(r) also showed good agreements with the
experiment. Thus, the eight centroid FHmodels gave very sim-
ilar M1 peak values that agreed with the experimental P(r)
curves, where M1 was 4.7–5.0 nm (Fig. 7C). Their intensities
were comparable, although these showed oscillations around
the experimental P(r) curves. Of note, the experimental P(r)
curves generally appeared smoother than the theoretical
curves. This is likely due to both the lower resolution and the
fluctuation between the alternative conformations of the solu-
tion structure studied by the experimental curves. Only eight of
the 200 best-fit structures had conformations inwhich both the
N- and C-terminal regions were inwardly bent, and none
Table 3
Experimental X-ray and analytical ultracentrifugation data for FH Tyr-402/Val-62 and His-402/Val-62 and their modeling fits
Filter Models Rg RXS-1 RXS-2 L R factor s20, w0
nm nm nm nm % S
Experimental data
FH Tyr-402/Val-62 7.39 0.25 2.21 0.06 1.77 0.01 28–29 5.66 0.08
7.35 0.13 2.27 0.06 1.77 0.01
7.61 0.01a
FH His-402/Val-62 7.77 0.27 2.02 0.06 1.76 0.01 26–28 5.69 0.02
7.22 0.15 2.15 0.06 1.75 0.01
7.54 0.01a
Atomistic modeling
Library of 29,715 FH models None 29,715 5.61–11.08 NAb NA NA 2.8–25.3 NA
FH Tyr-402/Val-62 (sample 1) Rg and R-factor 1240 7.02–7.75 NA NA NA 2.3–4.9 NA
Best fit 100 7.02–7.57 2.34–2.98 1.85–2.10 NA 2.3–3.2 5.35–5.77
PCA group 2 (NT out) 49 7.34–7.57 2.34–2.62 1.95–2.10 NA 2.7–3.2 5.38–5.77
Centroid 1 7.41 2.50 2.03 NA 3.1 5.52
FH Tyr-402/Val-62c (sample 2; data not shown) Rg and R-factor 2,678 6.98–7.72 NA NA NA 1.9–4.9 NA
Best fit 100 7.03–7.47 2.71–3.05 1.81–2.04 NA 1.9–2.7 5.33–5.70
PCA group 14 (NT in) 48 7.11–7.43 2.71–2.98 1.81–1.99 NA 1.9–2.7 5.36–5.70
Centroid 1 7.32 2.84 1.95 NA 2.2 5.49
FH His-402/Val-62 (sample 1) Rg and R-factor 1,219 7.38–8.16 NA NA NA 2.3–4.9 NA
Best fit 100 7.39–8.13 2.32–3.15 1.48–1.97 NA 2.4–3.6 5.21–5.61
PCA group 5 (NT in) 79 7.39–7.95 2.67–3.07 1.64–1.94 NA 2.5–3.6 5.21–5.55
Centroid 1 7.48 2.92 1.87 NA 3.2 5.44
FH His-402/Val-62 (sample 2; data not shown) Rg and R-factor 310 6.86–7.58 NA NA NA 2.7–4.9 NA
Best fit 100 6.86–7.57 2.09–2.93 1.82–2.10 NA 2.7–4.0 5.38–5.88
PCA group 19 (NT out) 84 6.86–7.57 2.28–2.82 1.89–2.10 NA 2.7–4.0 5.38–5.78
Centroid 1 7.40 2.48 2.03 NA 3.8 5.51
a The Rg, Rxs, and L values correspond to the SAXS curve extrapolated to zero concentration. The two Rg values correspond to the Guinier fits; the third corresponds to the
P(r) analyses.
bNA is not available.
c In this instance I62V was heterozygous; the other three were homozygous for Val-62.
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showed that both regions were extended in any structure. The
same PCA analyses for the other pair of available Tyr-402 and
His-402 curves gave similar structural outcomes (data not
shown).
The normalized Kratky analyses for six modeled best-fit
curves corresponding to the NT-in and NT-out centroid con-
formations from Fig. 12 each showed a clear peak that was sim-
ilar in shape to the experimental curves (Fig. 13). The QRg
range of the modeled peaks were 3.90–4.12 and 3.33–4.30,
respectively, in good accord with the observed values of 4.22–
4.48. This similarity showed that the modeling had mostly rep-
licated the extended flexible multidomain protein structures.
The reduced QRg peak positions for some of the models may
indicate an insufficient representation of flexible extended link-
ers in FH. Overall, this comparison validated our analyses that
FH is amultidomain proteinwhose domainswere connected by
semi-extended linkers (62).
Discussion
FH is an essential regulatory glycoprotein that protects host
cells from complement activation both at the cell surface and in
the fluid phase. In this study, themost accuratemolecularmod-
els to date have been produced for full-length FH, and these
suggest that FH exists in two distinct conformations that enable
its complement functions. Common and rare genetic variants
in FHare associatedwithmajor and rare inflammatory diseases,
including AMD, Alzheimer’s, aHUS, and C3G (34). For AMD,
the Y402H and V62I polymorphisms are associated with
Figure 9. Center-of-mass separation frequencies in the FH Tyr-402 and FHHis-402models. A andD, top two panels (gray) show the separations (NT-COM
and CT-COM) between the N-terminal -carbon (NT) and C-terminal -carbon (CT) to the center of mass (COM) for all 29,715 FH models. B and E, separations
are shown for the filtered1240 and1219 FHmodels (Fig. 8).C and F, separations are shown for the 100best-fit FHmodels. For each set of FHmodels, thedensity
plot shows the N-terminal half in blue, the C-terminal half in red, and the best-fit model as a cartoon.
Figure10.Separationdensities in theFHTyr-402andFHHis-402models.
For each of the Tyr-402 (A and B), joint NT-COM and CT-COM separations for
theFHTyr-402andFHHis-402models are comparedwitheachother.Blue/red
corresponds to the filtered FH models, and orange corresponds to the 100
best-fit FH models (Fig. 8).
Solution structures of FH Tyr-402 and His-402
J. Biol. Chem. (2018) 293(44) 17166–17187 17175
 at U
CL Library Services on January 23, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Solution structures of FH Tyr-402 and His-402
17176 J. Biol. Chem. (2018) 293(44) 17166–17187
 at U
CL Library Services on January 23, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
increased and decreased risk, respectively. To perform its reg-
ulatory activities, FH binds to multiple physiological ligands,
including to itself, with weak KD values in the micromolar
range, and has a highly glycosylated 20-domain structure (Fig.
1). For FH, characterization of its self-association is important
for determining its solution conformation and investigating the
development of drusen inAMD.Up to now, the self-association
of FH has only been characterized for native heterozygous FH
purified from plasma, and this has not been widely accepted.
Likewise, the only FH molecular structures up to now had
been determined by preliminary modeling of X-ray scattering
curves, resulting in two different folded-back structures whose
significance was unclear (26, 51, 67). Here, working with geno-
typed FH,we have now shown using four independentmethods
that WT FH Tyr-402 and risk-associated FH His-402 both sig-
nificantly self-associate. The V62I polymorphism involves a
minor structural rearrangementwithin the core of SCR-1 and is
protective for AMD due to its subtly better capacity to bind
C3b, inhibit proconvertase formation, and catalyze inactivation
of fluid-phase and surface-bound C3b (45, 56). For both poly-
morphisms, it was important to demonstrate that neither
affected FH oligomerization by self-association. More impor-
tantly, by working with genotyped FH samples with reduced
sample aggregation, and also by utilizing a much-improved
atomistic modeling procedure based on molecular dynamics
and Monte Carlo procedures and statistical assessments of the
outcome, we have determined similar detailed molecular mod-
els for both allotypes of full-length FH, including its eight FH
glycans. Our statistical validation of two alternative FH confor-
mations significantly improves our understanding of ligand
binding to FH and how this may be perturbed in its function.
Self-association of FH
FH self-association is important for FH function because this
will increase the local concentration of its ligand-binding sites.
FH oligomer formation in solution was first observed by X-ray
scattering (28). Another FH study at that time usedEM in vacuo
and gel filtration to deduce that FH was monomeric; however,
the low concentrations in use in that study would not have
favored dimer formation, and gel filtration is insensitive to FH
self-association (Fig. 2) (33). The FH fragments SCR-6/8 and
SCR-16/20 each formed dimers (26, 29–31). This outcome pre-
dicted that full-length FHwould formweak daisy-chainedmul-
timers through these two independent dimerization sites.
These multimers were indeed observed for heterozygous FH
previously by AUC as a series of small peaks at large S values, in
which the sedimentation equilibrium fits suggest that FH
dimers and trimers are initially formed reversibly below 1
mg/ml (26, 29). Higher FH concentrations favor the formation
of larger oligomers by further daisy-chaining to result in irre-
versible oligomers that can be removed by size-exclusion chro-
matography. Here, these small peaks were now observed again
for homozygous FH at 1.1 mg/ml (Fig. 3C). Biologically, given
that the plasma concentration of FH is around 0.7 mg/ml (19),
reversible dimers and trimers are expected to form in vivo. The
resulting clustering of FH on cell surfaces, when bound to sur-
face markers and C3b/C3d, is likely to enable broader surface
protection, thus being functionally significant (68). However,
the accumulation of FH by clustering through self-association
may also relate to the formation of soft drusen in AMD via
chronic inflammation, in particular if FH oligomer formation
becomes irreversible (69). Consistent with this, studies with
full-length FH showed that its affinity for both heparin and HS
was not altered by the Y402H polymorphism (39, 70, 71). It was
also found that FHmultimer formation is enhanced in the pres-
ence of zinc, which inhibits FH function (57). In this context,
the self-association of FH Tyr-402 and FH His-402 becomes of
interest. In this study, AUC showed that 11.7–12.8%multimers
were present for FH His-402 and FH Tyr-402 (Fig. 3D).
Because the occurrence of FH self-association had been
questioned (33, 72), other orthogonal techniques were utilized
in our study to confirm this. MS confirmed the existence of as
much as 23–28% FH dimer and trimer for both FH allotypes
(Fig. 4). SPR revealed self-association for both full-length FH
allotypes and for both SCR-6/8 allotypes (Fig. 5). SAXS analyses
of the Guinier I(0)/c, Rg, and RXS-1 parameters showed clear
concentration effects attributable to self-association (Fig. 7,
D–F). One immediate consequence of this outcome was the
need to allow for self-association effects in the SAXS structural
studies tomodel themonomeric FH structure. It was necessary
to extrapolate the scattering curves to zero concentration. FH
self-association has had a marked effect on earlier SAXS data
collection. The first FH studies gave an Rg value of 12.4 nm in
1991 (28), whichwas reduced to 11.4 nm in 2001 (50), then to an
extrapolated value of 8.90 nm in 2008 (26, 29), and now to
an extrapolated value of 7.22–7.77 nm (Fig. 7E). This reduction
in Rg is attributed to reduced aggregation in FH because of
improved protein handling (e.g. FH forms aggregates in storage
or when in transit); its occurrence may have caused the lack of
progress with the protein crystallization of FH to date.
Atomistic modeling of two FH conformations
The newmolecular modeling of the FH scattering curves has
benefitted from five improvements (54) as follows: (i) the appli-
cation of molecular dynamics to generate an initial full FH
structure; (ii) the use of 17 high-resolution SCR structures, in
distinction to up to 11–14 SCR structures previously; (iii) the
inclusion of eight energy-refined glycan chains in FH; (iv) the
use of rapid Monte Carlo simulations with the inter-SCR link-
ers to generate a large number of 29,715 physically realistic trial
FH structures; and (v) statistical analyses of the resulting
ensemble of best-fit structures. Interestingly, our previous two
2008 modeling studies had yielded alternative folded-back FH
structures with either the N- or C-terminal SCR domains in an
Figure 11. Principal component analyses of the 100 best-fitmodels for FH Tyr-402 and FHHis-402. For FH Tyr-402 (A and B) and FHHis-402 (E and F), the
100best-fitmodelswere groupedbyPCA into four groups, 1–4 (black, red, green, andblue, respectively), as exemplifiedby the first threeprincipal components
(PC2 versus PC1 and PC3 versus PC2). C and G, first three eigenvalue rankings (PC1 to PC3) accounted for variances of 98.5 and 86.9% in the 100 best-fit FH
models.D andH, black, red, green, and blue triangles correspond to the PCA groups 1–4 and 5–8 in each set of best-fit 100models. The four arrowed diamonds
correspond to the average (centroid) model for each PCA group.
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Figure12.Scatteringcurve fits for thecentroidPCAmodels forFH.For FHTyr-402 (A–D) andFHHis-402 (E–H). the fourpanelsdisplay thecentroidFHmodel
for the PCA groups 1–4 and 5–8, respectively, in density plots. The number of FH models in each PCA group is displayed. The experimental curve is denoted
by black circles, and the theoretical curve is denoted as solid blue/red lines. The inset shows the P(r) curves for the experimental data (black line) and modeled
curve (blue/red line). For each PCA group, the conformational space is represented as blue (NT),white or red (CT) density. The average (centroid) model of each
PCA group is depicted as a black cartoon in which SCR-1 and SCR-20 are arrowed.
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extended conformation (26, 51, 67), yet their significance was
unclear. Here, the statistical analysis of the 29,715 curve fits
showed that both alternative FH conformations were valid out-
comes from the SAXS modeling (Fig. 14, A and B). In the 200
best-fit structures, some 81 and 119 structures, respectively,
corresponded to (i) an extendedN terminus and a bent inwards
C terminus, and (ii) a bent inwardsN terminus and an extended
C terminus. In principal, either of these two FH structures may
be the actual solution structure, or both FH structures may
co-exist as an equilibrium in solution. Consideration of C3b
and C3d binding (below) suggested both FH conformations
exist. Further statistical analyses of the 200 best-fit structures
showed that the two FH Tyr-402 and His-402 allotypes dis-
played the same solution structures.
Biological significance of the FH Tyr-402 and His-402models
To summarize FHactivity, SCR-1/5 is involved in both cofac-
tor and decay-acceleration activities (73, 74), whereas SCR-
19/20 is involved in the recognition of host cell surfaces (75).
These two functions are mediated by N-terminal SCR-1/4
binding to both C3b and FI and C-terminal SCR-19/20 binding
to C3d, heparin, and sialic acid. C3dg and C3d, being two frag-
ments of C3 that each contain the thioester domain for host-
surface binding, are formed by the breakdown of C3b by FI
and/or serumproteases, and both bind to complement receptor
2 to trigger immune complex clearance and to stimulate the
immune response (1). C3d is also an autologous helper T-cell
target (76). During complement regulation at host cell surfaces,
an increase in the number of C3d-binding sites for SCR-19/20
would enablemore FH to be recruited at the host cell surface for
a more rapid breakdown of C3b (77). For cell-surface attach-
ment of FH, an optimal combination of affinities for each ofC3b
and polyanion ligand is essential for C-terminal FH binding
(68), for which both SCR-7 and SCR-19/20 bind bivalently via
heparin (21, 27).
The functions of FHwere clarified by superimposing the two
alternative best-fit conformations of FH with crystal structures
for the SCR-1–4-C3b complex and the SCR-19–20-C3dg com-
plex (PDB codes 2WII and 5NBQ) (52, 78).
(i) TheN-terminal extended FH conformation accounted for
binding to C3b at SCR-1/4, and to heparin and sialic acid, but
less so for C3dg. The binding of C3b to SCR-1/4 showed mini-
mal steric clashes with the rest of FH (black arrow, Fig. 14A).
Likewise, for binding to fluid phase FI, the SCR-1/3 domains
were accessible, including the FH residues 101, 106, 112, and
119 that were important for this interaction (52). For bivalent
SCR-7 and SCR-19/20 binding to heparin and/or sialic acid on
cell surfaces, the essential residues in each of SCR-7 (Tyr/His-
402) and SCR-19/20 (FH residues 1181–1183, 1191, 1195, 1196,
1198, and 1199) were solvent-accessible. However, C3dg bind-
ing to SCR-19 resulted in significant steric clashes with SCR-9,
SCR-12/15, and the glycans (black arrows, Fig. 14A), implying
that some structural rearrangement will be required for C3dg
binding.
(ii) In contrast, the C-terminal extended FH model ac-
counted for binding to C3dg at SCR-19 or SCR-20 and to
heparin and/or sialic acid on cell surfaces but not to C3b at
SCR-1/4. The binding of C3b to SCR-1/4 resulted in large steric
clashes with the SCR-6/8 domains (black arrows, Fig. 14B). The
shortest distance between the SCR-1/4 and SCR-6/9 domains
was 6 nm between SCR-1 and SCR-9. For binding to fluid
phase FI, the SCR-1/3 domains were accessible. The accessibil-
ity of the Tyr/His-402 residue in SCR-7 was not compromised.
For bivalent binding to heparin and/or sialic acid on cell sur-
faces, each of SCR-7 and the essential residues in SCR-19/20
(above)were accessible. ForC3dg binding to SCR-19 or SCR-20
(79), no steric clash was seen (Fig. 14B).
In summary, the two extended N-terminal and extended
C-terminal FH models (Fig. 14, A and B) showed that SCR-7
and SCR-19/20 were spatially aligned to permit simultaneous
bivalent FH binding to glycosaminoglycans at the host cell sur-
face. However, in order for FH to bind C3b via SCR-1/4, poten-
tial steric hindrance from SCR-6/8 would need to be removed,
most likely bymoving the flexible linkers between SCR-4/5 and
SCR-5/6 (52). Such large conformational changes in other com-
plement proteins have already been reported for the thioester
domain in C3b, and the Bb fragment from C3b within the C3
convertase (52). Interestingly, in the FH model with the com-
pact N terminus, the smallest distance between SCR-1/4 and
SCR-6/9 involved Arg-78 in SCR-1 and Asp-538 in SCR-9,
which bear opposite charges (80). We speculate that these
domains may electrostatically attract each other; indeed, con-
formational changes in FH with increase in ionic strength have
been reported (26). Further studies are required to investigate
such a proposed mechanism.
The existence of two FH conformations with different C3b
and C3d binding strengths accounts for previously reportedKD
values for each of SCR-1/4 binding to C3b (10–14 M) and
SCR-19/20 binding to C3b or C3d (1–5 and 0.2–8 M, respec-
tively). TheseKD values are similar to theKD value of full-length
FH binding to C3b (0.6–3 M) (21), indicating no synergy
between the two binding sites at SCR-1/4 and SCR-19/20, and
meaning that these two C3b and C3d sites are independent of
Figure 13. Normalized Kratky plots for the experimental and best-fit FH
curves. The four experimental curves are shown in blue and red for the Tyr-
402 andHis-402 allotypes, respectively, which peak atQRg values of 4.22 and
4.28, respectively. For both allotypes, the theoretical curves for four N-termi-
nal extended and two C-terminal extended FH models are shown as black
solid and dashed lines, respectively. These correspond to the two sets of cen-
troid models of Fig. 12, B, C, D, and H and Fig. 12, A and E, respectively.
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each other. This outcome is in concord with our N-terminally
extended and C-terminally extended FH models that bind to
C3b orC3d separately but not both together. In summary, FH is
seen with an N-terminally extended conformation that is able
to dismantle fluid phase C3 convertases, and alsowith a distinct
C-terminally extended conformation that binds to cell surfaces
via deposited C3d for enhanced local protection from comple-
ment activation. Both alternative conformations are able to
bind to glycosaminoglycans at the host cell surface, thus pro-
tecting this against excess C3b activity. Overall, the SAXS data
showed that FH underwent significant self-association, and the
modeling of these data for the monomer has resulted in the
proposal of two distinct FH conformations that would enable
FH to perform separate C3b or C3d binding functions in either
the fluid phase or at host cell surfaces, respectively.
Materials andmethods
Protein purification of FH and FH SCR-6/8
Thirty aliquots of 50–100 ml of human blood was collected
from anonymous healthy volunteers with ethical approval
(University College London, ID: 6986/001). The studies abide
by the Declaration of Helsinki principles. The Y402H and I62V
polymorphisms were identified by direct DNA sequencing of
their PCR product. PCR was performed with Extensor Hi-Fi-
delity PCRmastermix fromABgene following themanufactu-
rer’s protocol. Bidirectional sequencing of the PCRproductwas
carried outwith BigDyeTerminator version 3.1 on a 3730DNA
Analyzer (Applied Biosystems, Cheshire, UK). Homozygous
FH Tyr-402, which was homozygous or heterozygous at I62V,
and double homozygous FH His-402/Val-62 were purified
using monoclonal affinity chromatography with an MRC-
OX23–Sepharose column (29, 81). Bound FH was eluted from
the column using 3 M MgCl2, pH 6.9, and then dialyzed into
HEPES buffer (10 mM HEPES, 137 mM NaCl, pH 7.4) in the
presence of 0.5 mM EDTA to remove Mg2. To avoid cross-
contamination between different FH samples, the MRC-OX23
column was washed with guanidine (0.2 M Tris, 4 M guanidine-
HCl, pH8.0) between purifications. Each FH samplewas passed
through a HitrapTM protein G HP column to remove residual
IgG contaminant. Nonspecific aggregates and human serum
albumin were removed by gel filtration on a SuperoseTM 6 prep
grade XK 16/60 column (Fig. 2). Protein concentrations were
determined using an absorption coefficient of 16.2 for FH (Tyr-
402) and 16.1 for FH (His-402) (1%, 280 nm, 1 cm path length),
revised in the light of its known glycosylation (26). After sedi-
mentation velocity experiments on the purified FH allotypes,
the proteins were re-passed through the SuperoseTM 6 prep
grade XK 16/60 column to analyze the presence of FH oligo-
mers (Fig. 2).
Recombinant FH SCR-6/8 was purified as described previ-
ously (30). SCR-6/8 Tyr-402was expressed in BL21 (DE3) Esch-
erichia coli cells using a pET21ab vector system, whereas SCR-
6/8 His-402 was expressed in BL21 (DE3)pLysS E. coli cells
using a pET14b vector system. The protein was solubilized
from inclusion bodies, and the refolded protein was passed
through a HitrapTM 5-ml heparin HP column equilibrated in
Tris buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 7.4).
The bound protein was washed with Tris buffer and eluted
Figure 14. Best-fit FH centroid models superimposed onto C3b and C3dg. For both allotypes, the most representative N-terminal extended (A) and
C-terminal extended (B) FHmodels are shown as blue ribbon traces (left). These correspond to the centroidmodels shown in Figs. 12, B and E, respectively. The
coordinates are available for download in supporting Materials. These models were superimposed onto the SCR-1/4-C3b and SCR-19/20-C3dg crystal struc-
tures, in which C3b is shown as a yellow surface and C3dg is shown as a green surface (right, PDB codes 2WII and 5NBQ). The eight FH glycans are shown in
magenta. The cyan arrow indicates Tyr-402/His-402. Black arrows indicate steric clashes of FH with C3b or C3dg.
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with up to 1 M NaCl in Tris buffer. Proteins were dialyzed
into HEPES buffer for experiments, and their integrity was
routinely checked by SDS-PAGE before and after scattering
and ultracentrifugation.
Sedimentation velocity data
AUC data were obtained on two Beckman XL-I instruments
equipped with AnTi50 and AnTi60 rotors. Sedimentation
velocity experiments were performed at 20 °C at rotor speeds of
50,000 and 60,000 rpm in two-sector cells with column heights
of 12mm for five FHTyr-402 samples at 0.5, 1.1, and 2.1mg/ml
(3.2–13.6 M), and repeated for five FH His-402/Val-62 sam-
ples, all in HEPES buffer. Size-distribution analyses c(s) were
performed using SEDFIT (82, 83). SEDFIT provided shape and
size data using direct boundary Lamm fits of up to 300 scans
using a fixed resolution of 200, and floated the meniscus, the
bottom of the cell, the baseline, and the average frictional ratio
f/f0 (initial value 1.781), until the overall rootmean square devi-
ation and agreement between the observed and calculated sed-
imentation boundaries were satisfactory. The percentage frac-
tion of oligomers in the total loading concentrationwas derived
using the c(s) integration function. Other details are described
elsewhere (26, 29).
Mass spectrometry data
Mass spectra were acquired on aQ-ToF (quadrupole-TOF) 2
MS instrument for high mass operation and equipped with a
Z-spray nanoflow source (Waters, Manchester, UK) (84). The
following instrumental parameters were used: capillary voltage
1.7 kV; cone voltage 80–120 V; cone gas 100 liters/h; collision
cell voltage up to 200 V; ion transfer stage pressure 0.004–0.02
mbar; and argon collision gas at a collision cell pressure of 2.5
bar. Mass spectra were analyzed using the software Data-Ex-
plorer. Purified FH samples were concentrated to a final con-
centration of about 4 mg/ml (26 M), and then dialyzed over-
night into 140 mM or 1 M ammonium acetate at pH 7.5 for
measurement the next day. One pair of FH Tyr-402 and His-
402 allotypes was analyzed in both buffers.
Surface plasmon resonance data
The binding of the FH Tyr-402 and His-402 allotypes to
immobilized FH and that of the SCR-6/8 Tyr-402 and His-402
allotypes to immobilized FH SCR-6/8 were studied using a
Biacore X100 with version 1.1 of its evaluation software (GE
Healthcare, Uppsala, Sweden). For both the self-association
studies and the human serum albumin control, FHwas coupled
to a carboxymethylated dextran (CM3) research grade sensor
chip with a shorter carboxymethylated dextran matrix than a
standard CM5 chip, which gave nonspecific binding (85). Each
FH SCR-6/8 allotype was coupled to a CM4 research grade
sensor chip with a low degree of carboxymethylation compared
with a CM5 chip. Immobilizations utilized a standard amine
coupling procedure according to the manufacturer’s protocol.
FH (20 g/ml) or SCR-6/8 (10 g/ml) in 10 mM acetate buffer,
pH 5.5 (FH), was injected over flow cell 2 to reach a maximum
response of 150 RU. A control surface cell was prepared iden-
tically on flow cell 1 but without protein immobilization. Equi-
librium analyses were performed at 25 °C using Biacore X100
wizards at a flow rate of 30 l/min. The running buffer was
HEPES buffer. FH Tyr-402 was injected for 180 s at six concen-
trations between 0.1 and 1.5 mg/ml (0.7–9.7 M). FH His-402
was injected at six concentrations between 0.1 and 1.8 mg/ml
(0.7–11.7M). SCR-6/8 Tyr-402 was injected for 150 s over the
CM4 chip immobilized with either the Tyr-402 or the His-402
allotype at concentrations of 0.1–0.8 mg/ml (5–40 M). SCR-
6/8His-402was injected over theTyr-402CM4 chip at concen-
trations of 0.1–0.6mg/ml (5–28M) andover theHis-402CM4
chip at concentrations of 0.1–0.5 mg/ml (5–22 M). For the
SCR-6/8 analyses, the CM4 chips were used with 0.3 mg/ml
nonspecific binding reducer (GEHealthcare, Uppsala, Sweden)
added to each sample to reduce nonspecific binding to dextran
surfaces. Regeneration after each run was achieved by pulsing
with 10 mM sodium acetate buffer, 5 M NaCl, 0.05 mM EDTA,
pH 7.0, across both flow cells twice for 45 s. The maximum
binding response value in each run was fitted to a steady-state
1:1 affinity model.
X-ray scattering data
SAXS data were acquired in two sessions on Instrument
ID02 (86) at the European Synchrotron Radiation Facility
(Grenoble, France) with a ring energy of 6.0 GeV and operating
in four-bunch mode. Storage ring currents were 30–44 and
68–89 mA, and the sample-detector distances were 2 and 3 m,
respectively. Radiation damage was eliminated by the continu-
ous movement of the sample in its capillary flow cell during
beam exposure, the use of 10 time frames of duration between
0.1 and 0.5 s each during each acquisition, and on-line checks
for the absence of radiation damage at lowQ. Two FH Tyr-402
and two FHHis-402 allotypes were each studied at five concen-
trations between 0.4 mg/ml (2.6 M) and 3.3 mg/ml (21.4 M).
Measurements were done in HEPES buffer. Other details
including data reduction are described elsewhere (30, 31).
In a given solute-solvent contrast, the radius of gyration (Rg)
is a measure of structural elongation if the internal inhomoge-
neity of scattering densities within the protein has no effect.
Guinier analyses at lowQ gives the Rg, and the forward scatter-
ing at zero angle I(0) (87) as shown in Equation 1,
lnI	Q
 lnI	0
	 RG
2Q2/3 (Eq. 1)
This expression is valid in aQRg range up to 1.5. If the struc-
ture is elongated, themean radius of gyration of cross-sectional
structure RXS and the mean cross-sectional intensity at zero
angle (I(Q)Q)Q3 0 are obtained from Equation 2,
ln(I	Q
Q) 	I	Q
Q
Q¡0	 RXS
2Q2/2 (Eq. 2)
The Rg and RXS parameters were calculated using the SCT
suite of programs (88). Indirect transformation of the scattering
data I(Q) in reciprocal space into real space to give the distance
distribution function P(r) was carried out using the program
GNOM: (89)
P	r
 
1
22
o

I	Q
Qr sin(Qr)dQ (Eq. 3)
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P(r) corresponds to the distribution of distances r between
volume elements. For this, the X-ray I(Q) curve utilized up to
207data points forQbetween 0.06 and 1.50 nm1 for 0.4mg/ml
FH, and increasing up to 308 data points forQ between 0.06 and
2.10 nm1 for 3.3 mg/ml FH. Other details are described else-
where (29–31, 50).
Atomistic FH scatteringmodeling
The first scattering modeling of the 20 SCR domains in FH
used NMR structures for three SCR domains and homology
models for the remaining 17 SCR domains (Fig. 1) (50). The
second modeling used NMR and crystal structures for 11–14
SCR domains, and homology models for the remaining 9 SCR
domains (26, 51). Here, a combination of MODELLER version
9.14 (90) and monomer Monte Carlo (SASSIE-web) (91) was
used to build a starting FHmodel fromNMR and crystal struc-
tures for 17 SCR domains and three improved SCR homology
models for SCR-9, SCR-14, and SCR-17 (Tables 1 and 2). For
the homology modeling, a template SCR structure without
linker residues was identified using the basic local alignment
search tool to search the Protein Data Bank server (BLAST-
PDB) (Table 2) (92), and its sequence was aligned to the tem-
plate sequence using Clustal Omega multiple sequence align-
ment (93). By this, low sequence identitywasmostly confined to
the loop regions, and the secondary structure was conserved.
These loop regions were modeled using the loop optimization
protocol in MODELLER. The best SCR model was selected
from a final dataset of 100 generated models using the normal-
ized discrete optimized protein energy (DOPE) score (94). For
the SCR-9, SCR-14, and SCR-17 homology models and the
NMR-based SCR-5 model (95), strained high-energy bonds
were relaxed to give physically stablemodels by energyminimi-
zation (500,000 steps) and molecular dynamics simulations
(1,000,000 steps) in the simulation engine NAMD version 2.9
(96). The PDB Reader input generator tool (97, 98) converted
the PDB file into CHARMM readable format, generated a pro-
tein structure file (PSF), including the disulfide bonds, and pro-
vided the CHARMM36 force-field files (99, 100). The quality of
the secondary structure was verified using Ramachandran plots
on the RAMPAGE server (101), the DSSP program (102, 103),
and visual comparison with other SCR domains. As required,
the Ramachandran plots showed a minimal number of outliers
in these four SCR models. To create the initial full-length FH
structure (Fig. 1), the 11 SCR fragment models (SCR-1/4,
SCR-5, SCR-6/8(His-402), SCR-9, SCR-10/11, SCR-11/12,
SCR-12/13, SCR-14, SCR-15/16, SCR-17, and SCR-18/20) were
aligned to the FH sequence sequentially using MODELLER.
Each of SCR-1/5, SCR-6/13, SCR-14/16, and SCR-17/20 were
assembled first, before their simultaneous alignment to the full-
length FH sequence. The best FH model was selected based on
the normalized DOPE score and then refined in NAMD to give
the final FH initial structure. FH was numbered from the N
terminus of the 18-residue signal peptide to follow HGVS con-
vention. Eight biantennary disialylated glycans (18) were added
to Asn-511 in SCR-9, Asn-700 in SCR-12, Asn-784 in SCR-13,
Asn-804 in SCR-14, Asn-864 and Asn-892 in SCR-15, Asn-
1011 in SCR-17, and Asn-1077 in SCR-19 (Fig. 1). For each
glycan–Asn Protein Data Bank (PDB) file, GlycanReader was
used to generate the CHARMM force field and PSF inputs for
energy minimization in NAMD. The resulting energy-mini-
mized glycans were positioned onto FH by superimposing the
Asn residues in PyMOL and then deleting the Asn residue in
the glycan PDB. Once all eight glycans had been added to FH
and accepted by GlycanReader, bash scripts were used to con-
vert the nomenclature and numbering of the glycan and protein
atoms to the format required for the torsion angleMonte Carlo
(TAMC) module in SASSIE-web. In this, the glycans were
moved with their attached protein segment and not varied
independently.
The model library of physically realistic FH structural con-
formations was generated by subjecting the inter-SCR linkers
to the TAMC module in SASSIE-web (104). Eleven of the 19
linkers were defined by high-resolution structures and were
therefore held fixed. The remaining eight linkers at SCR-4/5,
SCR-5/6, SCR-8/9, SCR-9/10, SCR-13/14, SCR-14/15, SCR-16/
17, and SCR-17/18 were moved (arrowed, Fig. 1). For each of
these linker residues, the backbone 
 and  torsion angles were
varied in steps of up to either 30 or 180o, except for the torsion
angles involving the conserved Cys residues at the start and end
of each linker. To maximize the sampling, four simulations
were run as follows: (i) 200,000 steps with up to 30°moves using
the FH initial model; (ii) 200,000 steps with up to 180° moves
using the FH initial model; (iii) 100,000 steps with up to 30°
moves using an FHmodel from simulations i and ii with its CT
bent inwards, and (iv) 10,000 steps with up to 30° moves using
the best-fit FH model from simulations i–iii. In a Monte Carlo
simulation, many moves result in structures with steric clashes
andwere discarded as physically unrealistic. In the present case,
the 510,000 attempted moves resulted in 15,136 (8%), 3720
(1%), 10,316 (10%), and 543 (5%) physically-realistic, acceptable
models, respectively. These were combined into a library of
29,715 models for SAXS curve fitting. A theoretical scattering
curve was generated from each model using SasCalc. SasCalc
calculates the scattering curve using an exact all-atom expres-
sion for the scattering intensity in which the orientations of the
Q vectors are taken from a quasi-uniform spherical grid gener-
ated by the golden ratio (105).
For each of the Tyr-402 and His-402 allotypes, the experi-
mental scattering curve with 221 data points was extrapolated
to zero concentration to eliminate the contribution of self-as-
sociation. These were compared with the theoretical curves
using the R-factor shown in Equation 4,
R  
Qi
	Iexp(Qi
	 Imodel(Qi))
Iexp(Qi)
(Eq. 4)
where Qi is the Q value of the ith data point; Iexp(Qi) is the
experimental scattering intensity; and Imodel(Qi) is the theoret-
icalmodeled scattering intensity (88). For SasCalc, the lowestQ
values before the Guinier Rg region in the extrapolated scatter-
ing curves were interpolated to zero Q using MATLAB. After
interpolation, the original 221 I(Q) values betweenQ of 0.0 and
1.5 nm1were retained to define theQ spacing for SasCalc. The
R-factor versus Rg graphs were similar for the extrapolated and
0.4 mg/ml curves, whereas those from curve fitting at 0.7, 1.1,
and 2.2 mg/ml gave worse R-factors (data not shown), as
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expected. For each of the four Tyr-402 and His-402 curves, the
29,715 models were filtered on both Rg and R-factor. Models
were accepted if their Rg values were within5% of the exper-
imental Rg values (Table 3), and their R-factor was 5%. The
best-fit 100models were identified by ranking the filteredmod-
els by their R-factors. The Y402H polymorphism had no effect
on the curve fits, leading to an R-factor difference of only
0.0003%.
The SCR domain arrangement in the 29,715 FH models was
parameterized using the separations between the FHCOMand
the NT and CT -carbon atoms. Separations were calculated
using Tcl scripting within Visual Molecular Dynamics (VMD)
software (106), and their frequencies were displayed as histo-
grams using R (107) for statistical analyses. To assess the nor-
mality of the separation distributions, Quantile-Quantile plots
and two-tailed Kolmorogov-Smirnov tests were employed
using the ks.test statistical function in R (107, 108). Here, the
null hypothesis stated that the distribution was consistent with
the normal distribution, and a Bonferroni-corrected signifi-
cance level of 0.05 divided by 2 (0.025) was set. The Kolmoro-
gov-Smirnov test calculated the maximum vertical deviation
between the two curves as the test statisticD and the probability
of D occurring due to chance (p value). To compare the distri-
butions for all 29,715 models, the 310–2678 filtered models,
and the best-fit 100 models of the two allotypes, their distribu-
tions were converted to cumulative density frequencies and
compared using the two-tailed Kolmorogov-Smirnov test in R
with the ks.test statistical function. Here, for each comparison,
the null hypothesis stated that the distributions were the same
and a Bonferroni-corrected significance level of 0.05 divided by
12 (0.00417) was set. To visualize the resulting conformations
after applying the Rg and R-factor filters, the filtered models
were superimposed with the reference FH model using SCR-
10/13, and visualized as density plots using SASSIE-web.
Principal component analysis (PCA) provided by the Bio3d
package in R (108) identified four major conformational states
in the best-fit 100models. For both allotypes, PCA satisfactorily
accounted for 80% of the variance between the models. The
average FH structure for each PCA groupwas identified using a
centroid model computed using R. The SCR domain arrange-
ment of each PCA group was identified by a density plot using
SASSIE-web. To assess the conformational differences between
the two allotypes, the frequencies of the twomajor SCR domain
arrangements were compared by using the two-tailed Fisher’s
test for a 2  2 contingency table in GraphPad QuickCalcs
(https://www.graphpad.com/quickcalcs/).4 Here, the null hypo-
thesis stated that the proportion of FHmodels with an inward-
ly-bent NT and extended CT, compared with an extended NT
and inwardly-bent CT, were the same. The significance level
was set as 0.05, and the probability of the difference occurring
due to chance (p value) was computed. To see whether these
two conformations could be distinguished by their SAXS
curves, the difference in scattering intensity between their best
fitting centroid model curves was calculated and visualized
using R. The FH models were assessed by superimposing the
centroid model for each of the largest ensembles with crystal
structures for the FH-ligand complexes of SCR-1/4 with C3b
and SCR-19/20 with C3d using PyMOL (PDB codes 2WII and
5NBQ) (52, 78).
For theAUCmodeling, the theoretical s20, w0 values for the FH
models were calculated directly from the atomic coordinates
with the default value of 0.31 nm for the atomic element radius
for all atoms to represent the hydration shell by using the
HYDROPRO shell modeling program (109). The molecular
weight and partial specific volume for FH used followed that
used previously (26, 110). FH glycosylation was considered by
using the compiled partial specific volumes for saccharides
(111).
Links to web servers and tools
The following were used: BLAST (https://blast.ncbi.nlm.nih.
gov/Blast.cgi)4; Clustal Omega (http://www.ebi.ac.uk/Tools/
msa/clustalo/)4; SASSIE-web (https://sassie-web.chem.utk.
edu/sassie2/)4; CHARMM-GUIGlycanReader (http://charmm-
gui.org/?docinput/glycan)4; CHARMM-GUI PDB Reader
(http://www.charmm-gui.org/?docinput/pdbreader)4;
RAMPAGE (http://mordred.bioc.cam.ac.uk/~rapper/)4; DSSP
(http://swift.cmbi.ru.nl/gv/dssp/)4; and GraphPad QuickCalcs
(https://www.graphpad.com/quickcalcs/contingency1/).4
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